This inventor holds 5 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: Takeda Chemical Industries, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals U.s.a., Inc.. Active years: 1996-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Habikino, JP (1996 - 1997)
- Osaka, JP (2001 - 2014)
- Kanagawa, JP (2020)
Company Filing History:
3 out of 1,858 
1 out of 1,229 
1 out of 24 Years Active: 1996-2020
Title: Keisuke Hirai: A Pioneer in Therapeutic Innovations
Introduction: Keisuke Hirai, an accomplished inventor based in Osaka, Japan, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of five patents, Hirai's work is focused on developing innovative treatments for complex medical conditions.
Latest Patents: Among his latest patents, one notable invention is a prophylactic or therapeutic agent for autism spectrum disorder. This invention utilizes a compound with melatonin receptor affinity, presenting a novel approach to addressing challenges associated with autism. Additionally, he has developed pharmaceutical compositions and methods for treating age-related macular degeneration using melatonin analogues, illustrating his dedication to tackling critical health issues through innovative research.
Career Highlights: Throughout his career, Hirai has been associated with prominent companies such as Takeda Chemical Industries, Inc. and Takeda Pharmaceutical Company Limited. His role within these organizations has positioned him at the forefront of pharmaceutical innovation, allowing him to pursue research that bridges scientific inquiry with practical solutions.
Collaborations: Keisuke Hirai has collaborated with notable colleagues like Giichi Goto and Yuji Ishihara. Together, they have combined their expertise to drive advancements in therapeutic agents, pushing the boundaries of what is possible in medical treatment.
Conclusion: Keisuke Hirai's contributions to the field of pharmaceuticals highlight his role as a visionary inventor. With his innovative patents targeting autism and age-related macular degeneration, he stands as a key figure in the ongoing evolution of medical therapies, underscoring the importance of creativity and collaboration in addressing complex health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile